UNITY BIOTECHNOLOGY INC - COM (UBX)

CUSIP: 91381U101

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM
Total 13F shares
21,794,012
Share change
+1,696,133
Total reported value
$157,133,011
Price per share
$7.21
Number of holders
75
Value change
+$12,328,028
Number of buys
51
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 91381U101?
CUSIP 91381U101 identifies UBX - UNITY BIOTECHNOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY INC - COM (UBX) as of Q4 2019

As of 31 Dec 2019, UNITY BIOTECHNOLOGY INC - COM (UBX) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,794,012 shares. The largest 10 holders included FMR LLC, BAILLIE GIFFORD & CO, BlackRock Inc., Invus Financial Advisors, LLC, Capital World Investors, Mayo Clinic, VANGUARD GROUP INC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and CITADEL ADVISORS LLC. This page lists 75 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.